Experimental Drug Shows Promising Results For Men With Prostate Cancer - NY1

International Business Times

Experimental Drug Shows Promising Results For Men With Prostate Cancer NY1 “It has been used with patients post-chemotherapy. It's still a hormone, so it's very well tolerated and it shrinks prostate tumors and drops the PSA.” The drug binds to androgen receptors in cancer cells and blocks them from letting cancer grow. PSA Testing's Next LeveldailyRx Debating how and how often to test for prostate cancerNewsworks.org Prostate Cancer Drug: How to Find Clinical Trials of Promising MedInternational Business Times UroToday -Sacramento Bee all 15 news articles »

Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today

Benefit of Bone Drug in Prostate Cancer in Doubt MedPage Today By Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON -- FDA reviewers have questioned whether there would be much added benefit from expanding the indication for Amgen's denosumab (Xgeva) to prevent the spread of prostate cancer to ... and more »